New Genentech Data at the 2019 AAN Annual Meeting Showcase Breadth and Promise of Neuroscience Portfolio
Other NEWS
- 240 P
Drugs in Development for MS, Including Ofatumumab (with MS Neurology experts Lublin; Bar-Or; Calabresi; Coyle and Krieger)
RECENT POSTS ... - 240 PMS Research Has Been Ignoring the Black Community. It’s Time That Changed
RECENT POSTS ... - 240 PUSAID’s New Center for Water Security Signals Progress, But More is Needed
RECENT POSTSAs the COVID-19 crisis grew this spring, the U.S. Agency for International Development (USAID) revamped its Water Offic ... - 240 P
LEMTRADA: Who is the Right Patient for this Multiple Sclerosis Drug?
RECENT POSTSvlog produced by Aaron Boster, MD Click HERE to Subscribe for the MS Beacon Newsletter Information Shared ... - 240 PAccessing Justice: Femicide and the Rule of Law in Latin America
RECENT POSTS“The pandemic is just making visible a reality that has been going on for decades,” said Claudia Calvin, Founder of Muj ...
0 Comments: